Octave Specialty Group, Inc. (OSG) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 14, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the OSG SEC filings page.
Octave Specialty Group, Inc. (OSG) reported $320.7M in revenue over the twelve months to Jun 30, 2026, up 26.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Reported growth is being absorbed by a much heavier cost base, while 2025 balance-sheet shrinkage sharply reduced leverage.
Revenue nearly doubled from$124.7M in FY2023 to$251.2M in FY2025, yet the cost structure expanded faster than earnings capacity: SG&A more than doubled and depreciation and amortization rose about eightfold. That pattern helps explain why growth did not restore profitability, with FY2025 still reporting a loss after FY2023’s modest profit.
The balance-sheet footprint contracted sharply: total assets fell from
Operating cash flow shifted from
Financial Health Signals
Scored against insurers for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Octave Specialty Group, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Loss Ratio measures the claims an insurer paid out against the premiums it earned, so a lower ratio leaves more of every premium dollar with the company. Octave Specialty Group, Inc. scores 27/100 on it among other insurers.
Octave Specialty Group, Inc. reported revenue of $251.2M in fiscal year 2025, against $235.8M in fiscal year 2024. Premium Growth ranks insurers on the three-year path of the premiums they write rather than on total revenue, and Octave Specialty Group, Inc. scores 12/100 among other insurers.
Octave Specialty Group, Inc. funded 32.2% of its assets with shareholders' equity at the end of fiscal year 2025, holding $715.8M of equity against $2.2B of assets. Capital ranks insurers on that cushion, and Octave Specialty Group, Inc. scores 72/100 among other insurers.
Not available for Octave Specialty Group, Inc., and counted as zero in the overall score.
Combined Ratio puts claims and running costs together against premiums earned, and a figure under 100% means the underwriting made money before any investment income was counted. Octave Specialty Group, Inc. scores 6/100 on it among other insurers.
Octave Specialty Group, Inc. reported a net loss of $259.0M in fiscal year 2025, against a loss of $556.0M in fiscal year 2024. Stability ranks insurers on how steady net income has been across five years, and Octave Specialty Group, Inc. scores 5/100 among other insurers.
Octave Specialty Group, Inc. passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, both operating efficiency signals pass.
Octave Specialty Group, Inc. reported a net loss of $259.0M while operations used $52.3M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Octave Specialty Group, Inc. generated $83.0M in revenue in Q2 2026. This represents an increase of 51.0% from the same quarter a year earlier. Against the prior quarter it is down 20.3%.
Octave Specialty Group, Inc. reported -$12.2M in net income in Q2 2026. This represents an increase of 83.3% from the same quarter a year earlier. Against the prior quarter it is down 77.4%.
Octave Specialty Group, Inc. earned -$0.33 per diluted share (EPS) in Q2 2026. This represents an increase of 78.1% from the same quarter a year earlier. Against the prior quarter it is down 153.8%.
Not reported for Q2 2026.
Cash & Balance Sheet
Octave Specialty Group, Inc. held $79.1M in cash against $155.5M in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Octave Specialty Group, Inc.'s net profit margin was -14.6% in Q2 2026, showing the share of revenue converted to profit. Against the prior quarter it is down 8.1 percentage points. No change is given against Q2 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Octave Specialty Group, Inc.'s ROE was -1.7% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 6.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.
Not reported for Q2 2026.
Not reported for Q2 2026.
Capital Allocation
None of these metrics is reported for Q2 2026.
OSG Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $83.0M+51.0% | $104.2M+66.0% | $66.9M+2.6% | $66.6M-4.9% | $55.0M+7.7% | $62.8M+26.6% | $65.2M | $70.0M-5.4% |
| SG&A Expenses | $51.4M+26.8% | $53.2M+38.0% | $58.8M+45.5% | $53.7M+22.1% | $40.5M+45.5% | $38.5M+119.2% | $40.4M+90.8% | $44.0M+145.6% |
| Interest Expense | $2.8M-50.2% | $2.1M-61.7% | $1.4M+105.4% | $6.2M-69.1% | $5.6M-65.2% | $5.5M | -$26.6M | $20.0M+25.0% |
| Income Tax | $485K+122.3% | -$481K+22.0% | $9.2M+446.5% | -$1.2M-43.1% | -$2.2M-7140.0% | -$617K-574.6% | $1.7M | -$867K-186.7% |
| Net Income | -$12.2M+83.3% | -$6.9M+85.2% | -$27.0M+95.1% | -$112.6M-309.5% | -$73.0M-9627.1% | -$46.4M-323.3% | -$548.3M-3394.8% | -$27.5M-141.8% |
| EPS (Basic) | -$0.33+78.1% | -$0.13+89.3% | -$0.82+92.0% | -$2.35-273.0% | -$1.51-7450.0% | -$1.21-375.0% | -$10.23-4162.5% | -$0.63-143.8% |
| EPS (Diluted) | -$0.33+78.1% | -$0.13+89.3% | -$0.82 | -$2.35-273.0% | -$1.51-7450.0% | -$1.21-375.0% | -$10.23-4162.5% | -$0.63-143.8% |
| Diluted Shares (Avg) | 45M-5.7% | 45M-4.2% | N/A | 48M+0.9% | 48M+4.1% | 47M+3.2% | N/A | 48M+1.9% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.
OSG Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.3B-73.2% | $2.3B-72.5% | $2.2B-72.4% | $2.1B-76.8% | $8.5B+4.1% | $8.3B-2.1% | $8.1B-4.4% | $9.3B+18.0% |
| Cash & Equivalents | $79.1M+250.9% | $93.5M+174.6% | $68.4M+131.2% | $27.5M-32.6% | $22.5M+54.5% | $34.1M+147.7% | $29.6M+303.2% | $40.8M+27.5% |
| Short-Term Investments | $82.5M-68.8% | $229.4M-12.8% | $146.4M+14.8% | $426.9M-79.4% | $264.1M-87.1% | $263.2M-87.4% | $127.6M-36.4% | $2.1B+3.4% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $534.3M+18.3% | $533.5M+24.3% | $540.3M+29.2% | $445.4M+2.6% | $451.8M+545.4% | $429.3M+513.3% | $418.2M+500.1% | $434.0M+520.0% |
| Total Liabilities | $1.3B-82.7% | $1.2B-82.4% | $1.1B-83.4% | $1.0B-86.4% | $7.3B+8.2% | $7.0B+0.7% | $6.9B-1.9% | $7.4B+13.5% |
| Long-Term Debt | $155.5M | $117.1M | $117.6M | $100.0M-80.7% | N/A | N/A | $0-100.0% | $518.0M+2.6% |
| Total Equity | $698.8M-18.7% | $712.6M-16.4% | $715.8M-10.3% | $843.4M-42.4% | $859.8M-37.1% | $852.2M-37.6% | $798.4M-41.4% | $1.5B+15.8% |
| Retained Earnings | $348.5M-42.6% | $363.8M-46.6% | $370.4M-45.8% | $491.7M-60.2% | $607.5M-52.0% | $681.5M-46.2% | $683.6M-45.1% | $1.2B-1.8% |
Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Non-Current Liabilities.
OSG Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$10.2M-576.1% | -$10.1M+20.1% | -$666K+99.1% | -$41.2M-184.1% | $2.1M-89.5% | -$12.6M-278.4% | -$75.6M-185.9% | $48.9M+344.7% |
| Depreciation & Amortization | $12.3M+25.9% | $12.2M+33.1% | $13.3M+38.2% | $9.7M+37.2% | $9.7M+503.5% | $9.2M+468.5% | $9.6M | $7.1M+558.4% |
| Stock-Based Compensation | N/A | $4.7M+101.0% | N/A | $2.1M-42.1% | $2.4M+6.8% | $2.3M+607.3% | N/A | $3.7M-7.7% |
| Investing Cash Flow | N/A | N/A | N/A | $247.3M+209.5% | -$3.3M+83.1% | $21.3M+7945.2% | N/A | -$225.8M-805.8% |
| Financing Cash Flow | N/A | N/A | $232.1M+230.2% | -$201.0M-196.4% | -$4.3M-977.8% | -$5.4M-308.1% | -$178.2M-145.5% | $208.6M+525.6% |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
OSG Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Net Margin | -14.6% | -6.6%+67.3pp | -40.4% | -169.1% | -132.8% | -73.9%-115.8pp | -840.6% | -39.3%-128.3pp |
| Return on Equity | -1.7%+6.7pp | -1.0%+4.5pp | -3.8%+64.9pp | -13.4%-11.5pp | -8.5%-8.4pp | -5.4%-7.0pp | -68.7%-67.5pp | -1.9%-7.1pp |
| Return on Assets | -0.5%+0.3pp | -0.3%+0.3pp | -1.2%+5.6pp | -5.2%-4.9pp | -0.9%-0.9pp | -0.6%-0.8pp | -6.8%-6.6pp | -0.3%-1.1pp |
| Debt-to-Equity | 0.22-8.3x | 0.16-8.1x | 0.16+0.2x | 0.12-0.2x | 8.49+8.1x | 8.26+7.9x | 0.00-0.4x | 0.350.0x |
| Asset Turnover | 0.040.0x | 0.050.0x | 0.030.0x | 0.030.0x | 0.010.0x | 0.010.0x | 0.01 | 0.010.0x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Where Octave Specialty Group, Inc. Ranks
Frequently Asked Questions
What is Octave Specialty Group, Inc.'s annual revenue?
Octave Specialty Group, Inc. (OSG) reported $251.2M in total revenue for fiscal year 2025. This represents a 6.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Octave Specialty Group, Inc.'s revenue growing?
Octave Specialty Group, Inc. (OSG) revenue grew by 6.5% year-over-year, from $235.8M to $251.2M in fiscal year 2025.
Is Octave Specialty Group, Inc. profitable?
No, Octave Specialty Group, Inc. (OSG) reported a net income of -$259.0M in fiscal year 2025.
How much debt does Octave Specialty Group, Inc. have?
As of fiscal year 2025, Octave Specialty Group, Inc. (OSG) had $68.4M in cash and equivalents against $117.6M in long-term debt.
What is Octave Specialty Group, Inc.'s return on equity (ROE)?
Octave Specialty Group, Inc. (OSG) has a return on equity of -36.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Octave Specialty Group, Inc.'s operating cash flow?
Octave Specialty Group, Inc. (OSG) recorded an outflow of $52.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Octave Specialty Group, Inc.'s total assets?
Octave Specialty Group, Inc. (OSG) had $2.2B in total assets as of fiscal year 2025, including both current and long-term assets.
What is Octave Specialty Group, Inc.'s debt-to-equity ratio?
Octave Specialty Group, Inc. (OSG) had a debt-to-equity ratio of 0.16 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Octave Specialty Group, Inc.'s return on assets (ROA)?
Octave Specialty Group, Inc. (OSG) had a return on assets of -11.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Octave Specialty Group, Inc.'s P/E ratio?
Octave Specialty Group, Inc. (OSG) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $225.3M as of Sep 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Octave Specialty Group, Inc.'s price-to-sales ratio?
Octave Specialty Group, Inc. (OSG) trades at 0.7x sales, its market capitalization divided by revenue of $320.7M revenue, trailing 12 months to June 30, 2026. The market capitalization is $225.3M as of Sep 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Octave Specialty Group, Inc.'s Piotroski F-Score?
Octave Specialty Group, Inc. (OSG) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Octave Specialty Group, Inc.'s earnings high quality?
Octave Specialty Group, Inc. (OSG) reported a net loss of $259.0M while operations used $52.3M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Octave Specialty Group, Inc.?
Octave Specialty Group, Inc. (OSG) scores 20 out of 100 on our Financial Health Score, indicating weak standing within its insurers peer group. The score is a 0-100 composite of six dimensions (Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.